WallStSmart

Berkshire Hathaway Inc (BRK-A)vsDrugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BRK-A leads profitability with a 22.3% profit margin vs 0.0%. BRK-A trades at a lower P/E of 12.7x. BRK-A earns a higher WallStSmart Score of 73/100 (B).

BRK-A

Strong Buy

73

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 5.0Quality: 8.5
Piotroski: 4/9Altman Z: 2.59

DMAA

Avoid

34

out of 100

Grade: F

Growth: 5.7Profit: 3.5Value: 4.0Quality: 5.3
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRK-A6 strengths · Avg: 9.7/10
Market CapQuality
$1.08T10/10

Mega-cap, among the largest globally

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Operating MarginProfitability
32.6%10/10

Strong operational efficiency at 32.6%

EPS GrowthGrowth
107.8%10/10

Earnings expanding 107.8% YoY

Profit MarginProfitability
22.3%9/10

Keeps 22 of every $100 in revenue as profit

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

DMAA1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Areas to Watch

BRK-A1 concerns · Avg: 2.0/10
PEG RatioValuation
9.682/10

Expensive relative to growth rate

DMAA4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$260.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : BRK-A

The strongest argument for BRK-A centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 22.3% and operating margin at 32.6%.

Bull Case : DMAA

The strongest argument for DMAA centers on Debt/Equity.

Bear Case : BRK-A

The primary concerns for BRK-A are PEG Ratio.

Bear Case : DMAA

The primary concerns for DMAA are Revenue Growth, Market Cap, Return on Equity. A P/E of 59.6x leaves little room for execution misses.

Key Dynamics to Monitor

BRK-A profiles as a mature stock while DMAA is a value play — different risk/reward profiles.

BRK-A is growing revenue faster at 10.0% — sustainability is the question.

BRK-A generates stronger free cash flow (5.6B), providing more financial flexibility.

Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BRK-A scores higher overall (73/100 vs 34/100), backed by strong 22.3% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Berkshire Hathaway Inc

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).

Visit Website →

Drugs Made In America Acquisition Corp. Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Drugs Made In America Acquisition Corp. (DMAA) is a special purpose acquisition company dedicated to revolutionizing the U.S. pharmaceutical sector through strategic partnerships with innovative healthcare firms. Focused on bolstering domestic drug production and mitigating supply chain risks, DMAA aims to enhance the accessibility and affordability of medications for American consumers. By harnessing advanced technologies and championing local manufacturing efforts, DMAA is poised to significantly influence the landscape of pharmaceutical access in the United States.

Want to dig deeper into these stocks?